# Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis

> **NCT02192164** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 126 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **BEHAVIORAL:** smoking questionnaire

## Key facts

- **NCT ID:** NCT02192164
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2017-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192164, "Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02192164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*